Multiple Poster Presentations Highlight the Depth and Novelty of MeiraGTx’s Technology Platforms for Gene and Cell TherapyLONDON and NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc ...

GEN2 is well tolerated with minimal toxicity and signs of pharmacodynamic activity in an ongoing Phase 1 dose escalation and expansion trial.GEN-1013 was studied in aggressive murine cancer models ...

Gene therapy is at the cutting edge of medicine, with exciting new products being developed and used to treat a wide variety ...

Real innovation rarely emerges from linear thinking. The best ideas arise when our minds either drift purposefully or operate ...

Several human pathogens exploit the kinetic forces generated by polymerizing actin to power their intracellular motility. Human cell-autonomous immune responses activate ...

The authors investigate volatility spillover across the Covid-19 pandemic, Russia-Ukraine conflict and the collapse of ...

Since the dawn of philosophy, thinkers from Plato to Kant have considered how beauty affects human experience, and whether it ...

The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...

Abstract: SLAM technology plays a crucial role in indoor mapping ... To addressing this issue this letter introduces a SLAM approach that ensures accurate mapping using normal vector consistency. We ...

Abstract: Emotional text-to-speech (TTS ... We introduce a novel emotion-adaptive spherical vector that effectively captures emotional style and intensity, along with a joint attribute style encoder ...

The application deadline is April 15, 2025. The application must be filled out online and submitted along with a 2 page abstract containing a synopsis of dissertation research, and a curriculum vita.